Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Vallerie McLaughlin"'
Autor:
Paul Forfia, Raymond Benza, Michele D'Alto, Teresa De Marco, Jean M. Elwing, Robert Frantz, Francois Haddad, Ronald Oudiz, Ioana R. Preston, Stephan Rosenkranz, John Ryan, Robert Schilz, Oksana A. Shlobin, Jean‐Luc Vachiery, Carmine Dario Vizza, Anton Vonk Noordegraaf, Margaret R. Sketch, Meredith Broderick, Vallerie McLaughlin
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 2, Pp n/a-n/a (2023)
Abstract Right heart (RH) structure and function are major determinants of symptoms and prognosis in pulmonary arterial hypertension (PAH). RH imaging provides detailed information, but evidence and guidelines on the use of RH imaging in treatment de
Externí odkaz:
https://doaj.org/article/ce8abfb9f6ab4b669e83e51505d50fe2
Autor:
Manreet K. Kanwar, Ryan J. Tedford, Thenappan Thenappan, Teresa De Marco, Myung Park, Vallerie McLaughlin
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 7 (2021)
Abstract An elevated right ventricular/pulmonary artery systolic pressure suggestive of pulmonary hypertension (PH) is a common finding noted on echocardiography and is considered a marker for poor clinical outcomes, regardless of the cause. Even mil
Externí odkaz:
https://doaj.org/article/542f1074ae464e0fbe80ebae9b6c20a1
Publikováno v:
European Respiratory Review, Vol 25, Iss 142, Pp 381-389 (2016)
While there have been advances in the field of pulmonary arterial hypertension (PAH), disease management remains suboptimal for many patients. The development of novel treatments and strategies can provide opportunities to target other mechanisms tha
Externí odkaz:
https://doaj.org/article/30b4eebf720f495bb9b1be96bfb07941
Autor:
Sean Gaine, Vallerie McLaughlin
Publikováno v:
European Respiratory Review, Vol 26, Iss 146 (2017)
Recent advances in the treatment of pulmonary arterial hypertension (PAH) have led to improved patient outcomes. Multiple PAH therapies are now available and optimising the use of these drugs in clinical practice is vital. In this review, we discuss
Externí odkaz:
https://doaj.org/article/28627df1218b4567acd96efff21f99d9
Publikováno v:
European Respiratory Review, Vol 22, Iss 130, Pp 423-426 (2013)
Externí odkaz:
https://doaj.org/article/89f2d53cdf0f45df83da16306299574a
Autor:
Marc Humbert, Rogerio Souza, Nazzareno Galiè, Vallerie McLaughlin, Gérald Simonneau, Lewis Rubin
Publikováno v:
European Respiratory Review, Vol 21, Iss 126, Pp 267-270 (2012)
Externí odkaz:
https://doaj.org/article/2e397590677b4514a4579334c6fec271
Publikováno v:
European Respiratory Review, Vol 23, Iss 134, Pp 408-409 (2014)
Externí odkaz:
https://doaj.org/article/20b1928293e04bbab43be668d0f674fa
Autor:
Jason, Weatherald, Athénaïs, Boucly, Anthony, Peters, David, Montani, Krishna, Prasad, Mitchell A, Psotka, Faiez, Zannad, Mardi, Gomberg-Maitland, Vallerie, McLaughlin, Gérald, Simonneau, Marc, Humbert
Publikováno v:
The Lancet. 400:1884-1898
Although it is a rare disease, the number of available therapeutic options for treating pulmonary arterial hypertension has increased since the late 1990s, with multiple drugs developed that are shown to be effective in phase 3 randomised controlled
Autor:
HUNTER GILLIES, MURALI M CHAKINALA, BEN DAKE, JEREMY P FELDMAN, MARIUS M HOEPER, MARC HUMBERT, ZHI-CHENG JING, JONATHAN LANGLEY, VALLERIE MCLAUGHLIN, RALPH NIVEN, STEPHAN H. ROSENKRANZ, XIAOSHA ZHANG, NICHOLAS S HILL
Publikováno v:
Chest. 162:A2325-A2329
Autor:
KELLY CHIN, SONIA JAIN, WILLIAM R AUGER, RAYMOND L BENZA, RICHARD N CHANNICK, DUANE DAVIS, CHARLES G ELLIOTT, FENG HE, KIM M KERR, MICHAEL M MADANI, VALLERIE MCLAUGHLIN, MYUNG H PARK, VICTOR F TAPSON, JEFFREY R TERRY, ANDREA LACROIX
Publikováno v:
Chest. 162:A2380-A2383